Maybe, and just maybe all the concerted campaign about this warrant fearmongering is all about short covering!

The grapefruit juice hack and his accomplices may be all have been working for that purpose.

Last post for today before leaving for a trip

For newbies and potential investors from an old timer:

Nothing is 20/20 only the hindsight.

We were insulted as bagholders when price dropped drastically from dollar land, yet we were defiant, average down;

We were insulted as bagholders when price further declined into one half of a dollar, yet we were defiant, average down;

We were insulted as bagholders when price continually declined into $0.20s, yet we were defiant, again averaged down;

We were insulted as bagholders when the price drop into teens, yet we were defiant, continued average down;

Despite the repeated prediction/assertion for the demise of our company due to depleted financing and increasingly dire financial difficulties, and likening the brilliant science being no more than some grapefruit juice, yet we were defiant, accelerating our seemingly destined endless share price average down,

because we believe in the science, the management as a whole who can bring DCVax platform into full play in the market, and stock prices will be ultimately reflecting on its fundamental value.

Most of our old timers now have held shares probably ten or even twenty times what we were initially desired for with an average share price in the range from $0.20s to slightly more than $1 because of repeated averaging downs. Yes we are all in the black now with the share counts ten or twenty times what we initially planned to have, showing a huge profit (in paper of course) much more than we have anticipated at this stage before top line data announcement, or partnership, or buyout.

Newbies and potential investors, we had been in a much harsher and more difficult situation, yet we were defiant, continued average downs in the past, and now most of us have averaged up, repeatedly. For me I have bought a significant number of shares averaging up in the range from $0.3s to $1.8, and again averaging down from $1.87 to $0.958 recently.

Now the brilliant science behind DCVax platform is about to be confirmed, the outcome of the trial is as clear as day. What have you been waiting for!

Gook luck to all, have a good rest in this beautiful Sunday, and happy investing!

Agreed evanstony. Some people have been busy spewing FUD centered now on warrant exercising in the coming weeks in a concerted and collaborated way via twitter, message boards and other social media.

Simply because they now realize that DCVax-L trial will be meeting its primary and secondary endpoints in the coming days, and a paradigm shift treatment is on the horizon, and that Novocure's good time will soon end.

As a result, tens of billion $$ are at risk as Novocure's Optune device will be readily replaced by DCVax-L;

I don't think at what we have known about the trial that the short will be dumb enough to not cover, plus a huge demand of shares in the waiting.

[These forces, the short, the pro-novocure force, and the huge demand of share force all want a low share price environment. It's easy to understand that, but there are always opposing forces. It's a competing game with unknown short-term (one or two days) outcome maybe but known near future outcome with unstoppable substantial share price rise]

Anybody against the trend now is like throwing himself into burning smelter

Thanks for the fuel!

[btw, I am not a subscriber so I could not use private message. So sorry for all who have send me messages there]

anders2211 you are absolutely right about that that Novocure had a MC of 5 billion 6 months after TLD, [and about $2 billion before TLD.]

BTW, as the rule of thumb, a drug/therapeutic vaccine company is usually value much much higher than a device company for obvious reasons.

So at least we should be valued much higher than Novocure.

If you reason anything NWBO for a few minutes, it would be very clear that investing in NWBO in the next few weeks should be quite an easy and pleasant thing:

Investors should not be focused on the known unknowns: 1) whether warrants and how many will exercise and sell onto the market or not in the near future; 2) would the naked short wolfpack take advantage of such an anxiety to make thing worse, and I bet they will but there will also be buy pressure from who I don't know; and how the stock price would react on the above and beyond, will it increase or decline by how much? and 3) in the near future when exactly will top line data be released, and are there any other news which could also be released before the top line data or shortly thereafter?

In other words, the stock price may either increase or decrease with unknown intensity? Which nobody know for certain, and why anyone should exhaust own time and energy on that?

Instead, we should be focused on the knows: 1) fundamentally nothing has changed, if not better, because we have now known for sure that the whole EU is onboard with the company for its adapted SAP and endpoints; 2) despite that the share price has been halved in recent days from around $2.5 to today's $1.1 (with an equivalent market cap from about $2 billion to today's $1 billon); 3) tens or twenties of millions of warrants have exercised, sold and added to the float (now about 808 million shares outstanding), and it would be reasonable to believe that roughly the equal number of shares may have sold short by some warrant holders with their future warrants as hedge; 3) top line data will be released probably before 20 Nov, but it could happen any day before that; 4) it's most likely there may be other possible news around 20 Nov;

Most importantly 5) we now know almost for certain that the top line data will be positive -- at least the primary OS endpoint and/or a few other secondary endpoints if not all will be med with statistically significant p values, and 6) for GBM alone DCVax-L is at least worthy of $10 billion if not $20 billion if approved by the four RAs (equivalent to about $10 to $20 per share).

At the market close last Friday, NWBO traded at about $1.1 per share or about $1 billion market cap. How confident do you believe we will reach $2 billion mc ($2.2 per share), $3 billion mc ($3 per share), $4 billion mc ($4 per share), … $10 billion mc ($10 per share), and $20 billion mc ($20 per share) after top line data release within the next two or three weeks? How much will be the factor considering other indications? How much will DCVax as a platform really worth?

I don't know what you think, nor your strategy and tactics in the next few weeks in terms of buying or selling or holding nwbo stock?

But for me, it's quite simple: as long as the fundamental has not changed as it is laid out above, $1 per share (about $1 billion mc) is a strong buy. As a matter of fact, I have added shares recently in the range from $1.87 all the way down to $0.958.

Ladies and gentlemen, stop torturing yourselves, and please look at the forest not the trees!

[Despite I don't think warrant holders are dumb enough to exercise prematurely for several dimes of profit instead of dollars, the above reasoning still applies]

Oh my god, a few pennies dropped thanks to mighty grape fruit juice therapist/rapist AF

Oh my god, a few pennies dropped thanks to corroborating hedges working in concert with the rapist

Oh my god, a few pennies dropped thanks to some newbies' constant chatters measuring how long and how big is the difference between an inch and two, swarming message board

Oh my god, the rapist knows nothing about the science, the trial design, the contemporary trials, and evolving landscape of immunotherapy.

Look at our Linda's no-ball hedge fund friends who can easily beat the hacks into pulps if they are willing to pump one or maybe just one half of million shares in the open market.

If they are not willing, we are collectively.

A Summary of Anything NWBO Today:

There is a concerted force composed of probably some warrant holders and short hedges who has determined to bring down the price, probably to as low as about $0.80s to fill the last unfilled gap, and in doing so to make a market capitulation;

As a result, price has been brought down from about $2.3 to today's $1 range from probably selling of tens to twenties of million shares from warrant exercising, exacerbated by some short selling, and fear mongering in social media;

But, nothing has changed fundamentally. Instead, EU and UK are fully confirmed today to accommodate company's endpoint adaptations via confirmation of German clinical registry, and it seems it's only a matter of time FDA will be confirmed as well;

The most vicious NWBO attacker, aka grapefruit juice guy, now has nothing to say about the company but expression of his worry for the common retail investors over possible further warrant excursing and selling after 1 Nov;

The market as of now at 12:08pm has answered: I will buy any share which is for sale at this price range.

And what's the big difference to have a future price movement from $0.80s to $10 or from $1 to $10, considering one may miss out.

This is my last post for today, Good Luck!

It's quite a telling: strong buy at this price because

If "the Biotech Chief Science Officer," the grapefruit juice guy has nothing to say about the science but worrying for us retail investors about warrant exercise in the near future,

1) he has quietly admitted the trial will be successful;

2) The recent shaking up may be not just simply warrant exercising, plus opportunistic some short selling, but a preparation for unknown Wall Street sharks to take reasonable positions before top line data;

3) The price has been brought down to a level which positions anyone who buys today can have a very substantial profit in the near future.

It's no brainier. Buy as many shares as you can afford, that what AF has actually told today.

The manipulator hedges are frustrated and about giving up their dirty tricks. [Because one share for sale is readily bought instantly!]

They determine to bring the price to high 0.80s or low 0.90s to fill the gap or whatever they call it, but could not do that just by selling seemingly abundant shares

Every share for sell is happily bought in the market around $1

Maybe we should help just stop buying for one minute, then the manipulator hedges would be able to fulfill their dream LOL

I personally have been buying in recent days, yesterday at $1.01 and up, and today at price $0.956 and up.

Some hedge fxxks are just too technical. No wonder the whole hedge industries have been lost costombers steadily for decade.

Nothing has changed fundamentally. Instead EU branch German clinical site has updated adapted endpoints -- the whole EU + UK are now confirmed, so is FDA which just a matter of time will be confirmed.

Tens and twenties of million warrants have been eliminated in recent days (exercised and dumped onto the market irresponsibly)

But price has been halved. Need to get more dry power to put into use.

Happy bottom fishing today:

Set order at $1.01 for 30k just for fun, thought it would never get there, but yes got filled

Today bought shares at $1.48, 1.28 as well.

Easy for old timers but maybe scary for newbies

No dump of warrant-converted shares yesterday ladies and gentlemen. and it was a down day which set perfectly for an up days ahead.

So the bleeding shall stop

Nothing change that if DCVax-L is successful, and it will based on what we have known (90% certainty), backed by the Market for rewarding us a above 1 billion of MC before top line data.

Resume uptrend soon

Happy I have bought those vulture hedges' shares in the range of 1.56-1.87

Consider TA no matter how beautiful it may be an entertainment; even fundamentals for small biotech is not really fundamentals

It just that eventually all will work out the way it should be

$30 end target price!

[And you know what, Linda refuses to sell me her shredded paper waste and she can pull randomly and stunt the market any time!]

A very tiny number of people kill, rape and post messages 24/4 day in and out with no interests in the underlining company whatever.

We are talking about the rule of thumb, not some extreme cases. Stop embarrassing yourself and wasting the time of investors.

Go to the board of stock you have invested, and start contributing there!

This last post of mine is in dedication to you man, be proud!

It's my prediction for next huge moving up as vultures sold enough, back from sunbashing, and news too full to be held.

"Clouds are gathering while wind underneath suddenly stops!" from my previous post.

btw, many people mistake endpoint changes for saving the "failed" trial, or improving the odds of success. The matter of fact is not.

It simply is to find an appropriate way to measure the efficacy of DCVax-L vaccine against GBM.

It's not change basically, it's adjustment or adaption! It's necessary.

A dozen of small Linda's "friends" vulture hedge funds, a vast number of (about 20k at least) instant mood-switch retail investors, some fungus likes who post day and night 24/7 for years "with no interests whatever in the company," and a long anticipated Topline data still in the waiting, this is what we have at the time being -- a stalled rally and a stagnation, all thanks to those Linda's vulture hedge friends, no guts, short-sighted, selling some warrant turned shares for sun-bashing at the time being.

Linda can randomly pick up any shredded piece of paper from her office garbage basket, and form a news release which can at least make retails once again nonsense talk here a whole day or two. But, that's not the Linda we know fortunately, and now even Les' bar show has been suddenly stopped.

Clouds are gathering while wind underneath suddenly stops!

Linda, can I offer 10,000 nwbo shares to buy the shredded paper in your garbage basket?

or maybe more.

That's why I bought in the range of $1.55 -$1.87 despite my average base is around $0.30s, and planned to hold shares after those vulture hedges are replaced by true friends.

Biggers, Thermooo, etc., how are you guys doing recently?

[I knew, I knew you were all laughing all the way to the bank, but let me quess, the bank may be too small for the bright future we will have for this wonderful company!]

Regarding available warrants as of 1 Nov 2020:

1) Yes, a big chunk of the warrants are in the hand of Linda, Les and the rest of the gang;

2) Another big chunk of the warrants probably have been sold long time ago, via either naked or legal shorting of shares or the combination against their own warrants, as these warrants were issued long before the recent share price rise, and the holders, believe it or not, had never been "friendlies" at the time. Nothing wrong with that that they came to nwbo to make money, and they are so called vulture hedges.

Since they sold, a lot of things have changed, eg, warrant extensions, EU revealed endpoint changes, Flaskswork acquisition, etc., share price has since appreciated substantially. A big part of the tail force behind all this is exactly these vulture hedges funds, the warrant holders who have bought back shares and plus in open market like a drunken sailor in adjusting their positions in accordance with positively changed situation. Now they genuinely sense the success rate is higher than the failure rate, and they become longs;

3) Linda has various and numerous ways to manage on when, how and what to be released, including Topline data, UK/US manufacturing update,official endpoint change news, potential partnership/buyout,conference, publication, loan from big banks/investment funds, and you name it.

It's a bit of uncertain and ambiguity but I don't think it's problem, a psychological problem maybe in short-term (a few days). If one should be worrying, they should be worrying about what kind of data we will be seeing.

In addition, if one thinks the stock will be as higher as $10 in one or two years, why selling at $2 or $3?

But make no mistake, there is always selling no matter what, and that's called market.

Some people by nature are nitpicks, which would be a good fit if working in factory floor as QA specialist.

Listen, Data has been locked as of 5 October. Statisticians have been working on the data shortly after that. By now, Linda, Steering Committee Experts, advisory board experts, and some selected independent experts have been advising the company after reviewing initial statisticians' report on topline so that the company can have a cascade of news released in a concentrated manner!

And news has been leaked, otherwise the share price would have not been so strong despite stupid/knee jerking investors always sold, even in face of supper stellar data, there will always been selling just like someone always nitpicks ...

[There have been more than tens to twenties of million shares traded every day recently. No retail investors and mama and papa shop funds can account for that

There has been a much broader and deeper trading foundation forming right before our eyes! No leak, no ways!]

Just caught up and saw your post.

I believe it's first Nov, followed by 15 December and Jan 2021. Yesterday about 3 million shares added to the float, which for most part accounted for the price collapse, while today much less, maybe a few hundred thousands of shares added, which is not enough to damp the price at the end.

Warrant exercising and selling to the market itself will not be a problem in Nov, Dec and Jan if topline data are announced before that, and the results are as good as we have expected, because there will be certainty from confirmed positive results, then no warrant holders will be dumb enough to exercise and sell for one or a few dollar profits because the price will be much highers as time goes by, so in that case I believe most will just hold.

In addition, I believe at least part if not a significant part of those warrants maybe naked, meaning the holders have sold/shorted against their warrants, probably occurring most likely before we knew the endpoint change in Eu clinical site at much lower price. As a result, the net warrant counts may be much less than what most people thought.

I believe buy pressure will come back again after yesterday's hiccup. I continued buying yesterday and today.

One more good sign is that Les has not appeared in the BigBiz show for quite a while. He may be doing rehearsal now for national mainstream media shows.

To satisfy your curiosity, my order was filled at 10:19:30 am, and I have pending order below that. Actually my earlier order at $1.75 never got filled despite some filled below that price.

Yes indeed. MMs knew and had to dispose those shares one way or the other. But there is an aftermath psychological impact which needs to be repaired.

Either a big fund/hedge takes the advantage to buy large sums of shares, or another positive news

Then we will make a full recover and plus.

It looked scary at the beginning of trading today but actually it has been a normal trading day to accommodate a few million new shares, which most likely are from almost-depleted-warrant exercising and selling into the market [most warrants are suspended until Nov, Dec, and next Jan]

We don't know this as retail investors, but big guys particularly MMs who know sooner or later they have to accommodate those few millions of shares, and they chose today as there is a mention of nwbo in a positive news report.

Of course, in event like this there are always carried away transactions from stop loss, short fanning the fire, and MMs of course want to own the shares at less costly as possible.

The story ends.

[If we are not recovering today, it will be soon, as psychologically such event always has a damage to the general market]

[I bought more shares around $1.87 today]

It becomes more and more looking like the recent sharp share price increase is in a big part the result of naked short covering which is ongoing and in a mini-scale:

1) A few very revealing and positive signs leading to almost a certainty that the trial will be successful, including Flaskswork acquisition, endpoint changes, EU buyin, etc.;

2) Ever increased awareness as a result of 1);

3) As share price appreciates continually day after day, it generates more awareness in the general market. The hedges who have participated in previous financing may add to their positions, and there may be a few new hedges who have been also onboard; and

4) Of course, Topline data any day now, which should be a slogan for the time being.

But, a Big But, according to my observation, the scale and trend of the volumes traded recently cannot account for all the above. Yes there has been definitely short covering, namely, those legally shorted (about 18 million as of 30 September) short covering,

But I strongly suspect it is most likely the recent sharp share price appreciation is in most part the result of naked short covering from the naked short wolfpack. According to the past estimate of Les, there could be well over 200 million naked short shares.

As a result, considering the continued increased market awareness and the much larger part of the naked shorted shares which have not yet been covered, the ongoing share price appreciation will continue.

Then, the topline data will be announced. If the results are as good as we have expected, there will be a further huge market awareness and shock in the market, not only does the short have to cover at any cost but there will be a huge unmed demand for shares from both the general market in general and hedge funds and institutions in specific (with risks removed, they will be readily onboard).

Above is just a touch of pure technicals. By now we should all know the huge potential of DCVax platform, and what we should expect if there is a buyout in terms of price.

Welcome new bloods, bye bye old timers!

Bye bye old timers and welcome again new comers!

It's a new world, new environment, and new dynamic for NWBO shareholders

We have had the journal article reporting blended and blinded trial data, which show promising and unprecedented results in some areas, and in general a worthy of approval data for GBM patients;

The subsequent update show data continued mature and got better and better;

then, FDA published "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry December 2019" https://www.fda.gov/regulatory-information/search-fda-guidance-documents/demonstrating-substantial-evidence-effectiveness-human-drug-and-biological-products, and NWBO adapted new endpoints in accordance with the new FDA guideline.

No one can get more clearer about the huge success of NWBO as of now, not only in GBM indication, but many, many beyond in the future

Now the market has to and has responded, and it's just beginning!

Bye Bye Old Timers, Welcome New Comers

Healthy and Inevitable Metabolism For

Life is Going on for Better in NWBO Land!

If you done your "de-risking," or "smart long" selling, let me know, but don't tell the short.

I have dry powder to accelerate incineration of the naked short wolfpack.

duplicated, ihub fails to handle high volume

WHAT I SAID YESTERDAY? Gap Up [Waiting a bit longer until some knee-jeering or the "smart ones" done their de-risking selling then we are up, up and up]

New endpoints, de-risk, huge awareness on the way, outright undervalued stock

Be ready for many gap up down the road!

"The significance of today's article titled "DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time" by By Joan Lappin

is Huge!!!

It's beginning of the final recognition by mainstream media in the US.

More to come! Huge Awareness!!

https://www.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/

"It is almost two years since I attended the Miami conference. I was not prepared to recommend it to you until now. I own it; Gramercy Capital and all of our clients own it. In recent weeks, NWBO has finally completed its Phase 3 trial. The data has been locked and sent off to the statisticians for evaluation"

http://www.gramercycapital.com/

Why Select Us?

Our concept is to concentrate our investments in a smaller group of stocks that we watch carefully and analyze ourselves. We work with our clients to determine the minimum number of stocks they are comfortable owning. Most choose a number between 8 and 15 stocks. Obviously, the approach enhances the impact on your portfolio of your winners. The same is true if a stock fizzles and goes down. Implicitly, this approach requires that you have the skills to do your own analysis (which we do!). It doesn't work if you must rely on an early call from a brokerage firm whose analyst might have changed his tune. And always, it must be recognized that we sometimes pick stocks that go down. However, the essence of excellent portfolio management is to find far more winners than losers.

Joan E. Lappin

Joan E. Lappin, our President and Chief Investment Officer, has 4 decades of Wall Street experience; first as a media and entertainment analyst and since 1980, as a portfolio manager. She has seen both bull markets and bear markets; and each more than once. Mrs. Lappin, who has been included in Marquis' Who's Who in the World, has managed assets for some of America's largest corporations and for high net worth individuals. Turn her decades of experience to your advantage.

Renowned as a "stock picker," Business Week has called Mrs. Lappin "an investment guru" and she has been well recognized as the subject of feature stories in such well known publications as The Wall Street Journal, Business Week, Newsweek, Barron's, Money, The New York Sun, Delta Sky Magazine, and USA Today, among many others. In February 2002, The New York Times' Sunday Business credited Mrs. Lappin with being the only analyst on Wall Street to spot phony accounting at Qwest Communications in 1998 when it was a Wall Street darling. "

Good timing

The significance of today's article titled "DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time" by By Joan Lappin

is Huge!!!

It's beginning of the final recognition by mainstream media in the US.

More to come! Huge Awareness!!

https://www.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/

"It is almost two years since I attended the Miami conference. I was not prepared to recommend it to you until now. I own it; Gramercy Capital and all of our clients own it. In recent weeks, NWBO has finally completed its Phase 3 trial. The data has been locked and sent off to the statisticians for evaluation"

http://www.gramercycapital.com/

Why Select Us?

Our concept is to concentrate our investments in a smaller group of stocks that we watch carefully and analyze ourselves. We work with our clients to determine the minimum number of stocks they are comfortable owning. Most choose a number between 8 and 15 stocks. Obviously, the approach enhances the impact on your portfolio of your winners. The same is true if a stock fizzles and goes down. Implicitly, this approach requires that you have the skills to do your own analysis (which we do!). It doesn't work if you must rely on an early call from a brokerage firm whose analyst might have changed his tune. And always, it must be recognized that we sometimes pick stocks that go down. However, the essence of excellent portfolio management is to find far more winners than losers.

Joan E. Lappin

Joan E. Lappin, our President and Chief Investment Officer, has 4 decades of Wall Street experience; first as a media and entertainment analyst and since 1980, as a portfolio manager. She has seen both bull markets and bear markets; and each more than once. Mrs. Lappin, who has been included in Marquis' Who's Who in the World, has managed assets for some of America's largest corporations and for high net worth individuals. Turn her decades of experience to your advantage.

Renowned as a "stock picker," Business Week has called Mrs. Lappin "an investment guru" and she has been well recognized as the subject of feature stories in such well known publications as The Wall Street Journal, Business Week, Newsweek, Barron's, Money, The New York Sun, Delta Sky Magazine, and USA Today, among many others. In February 2002, The New York Times' Sunday Business credited Mrs. Lappin with being the only analyst on Wall Street to spot phony accounting at Qwest Communications in 1998 when it was a Wall Street darling.

So the naked short wolfpack had no guts to dump 100k or more shares at the close to bring the price below $1.

Wow, broken nerve, even when Linda Powers once again sucked in doing financing.

Since this financing deal was settle in mid day of Monday according to thermo, by that time Linda had not been notified yet about topline data from statisticians.

Great, no leak yet after an almost a week of statisticians work on the data base; then maybe tomorrow.

Because no way information will not be leaked if the entire steering committee, advisory board are involved.

Gap up soon
[last post for me GL longs]

Linda should let me deal with you guys. Yes first she needs to hire me if I am willing:

The price based on the previous ten-day price is so low at about $0.71 is because it seemed you guys may have manipulated it down from $0.90s in anticipation of offering;

Linda Powers may or may not be aware EU clinicaltrial register would leak (update the site) with new ordered endpoints, which after confirmed by ander has been responsible for the recent days of share price rise from $0.70s to dollar land.

Besides the new endpoints, I believe Linda has other tricks if she is willing to divulge, to directly or indirectly contribute to further substantial share price appreciation.

So the deal you have had now at around $0.82 per share (increased from about $0.71 after recent share price surge) with whopping 30% warrants is utterly an supper good deal for you guys, again at the cost of retail investors.

For all the brilliance Linda has shown, she has one thing which consistently sucks, dealing with you guys for financing. As far as Les is concerned, he is just a clown.

below is your post I reply to:

My entities were $4M of this transaction. You may feel the purchase price was too low, but I had negotiated a $0.71 price this past Friday (using the prior 10-day trail). I signed my purchase agreement over the weekend (was waiting on a countersignature), but the company couldn’t get all other purchasers committed over the weekend. Once Monday hit, and the share price rose so strongly, Linda and Les called, apologized, but said they could no longer close at $0.71. So, credit them with a better price.

To move DCVax development forward briskly, capital is needed. If they didn’t complete a raise now, they would have to wait until after all the November milestones, and progress would slow.

Please put Smith and Adam F together into a dumpster. They have shown their irrelevance in the investment of nwbo for a long time.

One is too old to have a clear,foresight and even correct thinking while the other always has agenda being a hit man for the naked short wolfpack [without conspiring hedge shorts, he is not different than any bear posing in this board].

The chatters and discussions recently are almost all garbage except two PlusOne posts by anders2211 and ATLnsider.

Enjoy the ride in the uptrend!

Should I capitalize all blow:

How many days have the three world-known statisticians been handed over the key to the locked data?

How many days or hours do they need to produce topline or detailed listings and charts in accordance with the new SAP?

Are Linda and the experts notified with the results by now?

Can they who are in the know be all locked down and taken away their phones

Should or will the stock price goes steady up or gaps up into dollar land in a sudden or days[color=green][/color]

???

Regardless, it's now not whether it will but when

Now you are free to do whatever you want to do!

[Linda has a myriad of ways to push the stock up big, such as news of reapplying to NASDAQ, confirm EU and FDA nods to new SAP, new institutional interests, partnership deal, etc]

How many days have the three world-known statisticians been handed over the key to the locked data?

How many days or hours do they need to produce topline or detailed listings and charts in accordance with the new SAP?

Are Linda and the experts notified with the results by now?

Can they who are in the know be all locked down and taken away their phones

Should or will the stock price goes steady up or gaps up into dollar land in a sudden or days

???

Regardless, it's now not whether it will but when

Now you are free to do whatever you want to do!

Tryn2, it's impossible to know. Maybe Les or Linda has a sense on what percentage of those are held by the "unfriendlies"

If DCVax-l results show safety and efficacy, no unfriendlies regardless how many warrants they hold would make any difference as they will become insignificant in the face of a vast awakening of the market and its appetite.

In that case, if I were one of those "unfriedlies", I would definitely make a 180 degree turn, becoming a true long, because the ultimate goal of all investors, long, short, flip floppers is to make money.

And it would become easier for them to make more money by holding their warrants for a longer term, maybe years.

Of course, if we do see a short squeeze with share price increasing more than most have expected. Then, it's reasonable and rational for investors to sell a portion of their holdings, because the chance of the price will fall back is high.

I guess it will all be hinged on what the trial results will show.

BTW, if there is a leak, we will see some substantial volumes soon. The statisticians by now may have known what the topline is.

All your recent talking is just nonsense in the grand scheme of bringing the strength of DCVax platform into full play, with the most important and critical step of showing DCVax-L is effective and safe in treating GBM patients, thus showing the concept/MOA works

And that will be known within a short period of time after DL.

Investors buy stock based on both the potentials and fully diluted share counts of the underlining stock.

If the topline data shows the approval of concept, nothing you have talked about recently will make any sense.

Don't think those 200 million warrant/option holders are idiot who would be in a rush to exercise and lock profit; yes some of them would exercise part of it due to not fear of losing profit, but strategic and tactic reasons based on the situations of their individual portfolios.

When the whole market, or a big chunk of it, is salivating the huge potentials of DCVax platform, which has become a pretty much a sure thing, think what you have spewed in this board recently. That kind of talking doesn't make any sense.

Of course, people should lighten their positions if they don't believe the chance of success of DCVax-l, or rebalance their positions if they don't want to take too much of risks. All those are normal part of stock investment, particularly small biotech investment in the face of a binary event.

BTW, if warrant holders want to renegotiate an extension with the company, the company should decline because they would want to get more of it, and they already got too much at the cost of retails.

Don't think the market is stupid, which would not understand what the implications are if DCVax-L is shown both safe and efficacious in treating GBM patients.

Faced with the success, on which stock exchanges is our stock traded is really not that important. Any institutional funds will easily find a way to get around any hurdles if any, and onboard.

we all know you are "long" with menopause syndrome, and I can predict you will get over it after further aging.

Oh, the lost shares, the soured mood, the still young curve of learning about who Linda Powers is

We have left you behind at the stagnation station, and can barely hear your waning.

Fuel yourselves with rocket fuel, we can still meet at the airport in the north shore as we are moving steady at this stage lest you finally understand our fearless complex leader.

Then we can still fly together into blue sky.

Your choice!

For God sake, before today's (hard) data lock announcement it's soft data lock, and analyses.

The delay, the confusion!

Unless it's a sure thing now Linda will not commit announcing hard data lock

The soft data lock lands LL's SNO plenary spot and Late Breaker Abstract, resulted in substantial first two waves of share appreciation, along with Flaskwork acquisition.

Unless it's perfection, Linda Powers will not commit no return hard data lock. The results will be soon learned by statisticians in a few hours if the want who will forward the results to Linda Powers, etc.

The next wave of substantial share price appreciation will come, if not today, very soon.

No way there will be no leak!

It certainly doesn't mean the general public will get the results in a few hours after plugging data and running the computer, it does mean the statisticians who if they wish can get the results in a few hours of time.

From that, how things will proceed is anyone's guess. But as per the company's news, the general public is probably notified in a month or so time.

But news will be leaked in the meantime !!!

It's a mere few hours of labor to plug and get topline data from now locked data ![color=red][/color]